Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Travis

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Journal of Crohn'S & Colitis|June 5, 2015
Does Disease Extent Matter when Scoring the UCEIS?Simon Travis, Crispin Corte, Satish Keshav
European Journal of Gastroenterology & Hepatology|January 14, 2005
Ciclosporin use in acute ulcerative colitis: a long-term experienceSimon Campbell, Simon Travis, Derek Jewell
Gastrointestinal Endoscopy Clinics of North America|July 1, 2014
Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activityAlissa Walsh, Rebecca Palmer, Simon Travis
Intestinal Research|July 2, 2023
JAK inhibitor, a new player for treatment-refractory microscopic colitisAnne Druez, Simon Travis, Jean-François Rahier
Best Practice & Research. Clinical Gastroenterology|July 23, 2019
Interfering with leukocyte trafficking in Crohn's diseaseSujata Biswas, Robert V Bryant, Simon Travis
Rheumatology (Oxford, England)|January 14, 2020
Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalaciaRaj Amarnani, Simon Travis, Muhammad Kassim Javaid
Current Gastroenterology Reports|December 10, 2015
Endoscopic Disease Activity in Inflammatory Bowel DiseaseShara Nguyen Ket, Rebecca Palmer, Simon Travis
Gastroenterology|January 30, 2013
Reply: budesonideWilliam J Sandborn, Simon Travis, David Ballard
Alimentary Pharmacology & Therapeutics|November 3, 2023
Letter: 'No first among equals'Umang Arora, Saurabh Kedia, Simon Travis, et al.
Journal of Crohn'S & Colitis|September 11, 2019
The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing DataRussell D Cohen, Fatima Bhayat, Aimee Blake, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Journal of Crohn'S & Colitis|June 5, 2015
Does Disease Extent Matter when Scoring the UCEIS?Simon Travis, Crispin Corte, Satish Keshav
European Journal of Gastroenterology & Hepatology|January 14, 2005
Ciclosporin use in acute ulcerative colitis: a long-term experienceSimon Campbell, Simon Travis, Derek Jewell
Gastrointestinal Endoscopy Clinics of North America|July 1, 2014
Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activityAlissa Walsh, Rebecca Palmer, Simon Travis
Intestinal Research|July 2, 2023
JAK inhibitor, a new player for treatment-refractory microscopic colitisAnne Druez, Simon Travis, Jean-François Rahier
Best Practice & Research. Clinical Gastroenterology|July 23, 2019
Interfering with leukocyte trafficking in Crohn's diseaseSujata Biswas, Robert V Bryant, Simon Travis
Rheumatology (Oxford, England)|January 14, 2020
Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalaciaRaj Amarnani, Simon Travis, Muhammad Kassim Javaid
Current Gastroenterology Reports|December 10, 2015
Endoscopic Disease Activity in Inflammatory Bowel DiseaseShara Nguyen Ket, Rebecca Palmer, Simon Travis
Gastroenterology|January 30, 2013
Reply: budesonideWilliam J Sandborn, Simon Travis, David Ballard
Alimentary Pharmacology & Therapeutics|November 3, 2023
Letter: 'No first among equals'Umang Arora, Saurabh Kedia, Simon Travis, et al.
Journal of Crohn'S & Colitis|September 11, 2019
The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing DataRussell D Cohen, Fatima Bhayat, Aimee Blake, et al.
Pageof 17